ERTEBRAL fractures are the most common osteoporotic fracture-approximately one fourth of Caucasian, postmenopausal women in the US are affected.
-a procedure known as percutaneous PMMA-assisted vertebroplasty.
Presently, our ability to compare the effectiveness of different therapies in the treatment of VCFs is limited by the absence of a standardized instrument with which to specifically measure both pain and functional status both before and after treatment in elderly patients. Currently accepted, validated instruments fail to measure one or more important aspects of a patient's status. Consequently, in an effort to capture as much important information as possible, authors frequently will include several validated questionnaires, creating redundancies and lengthening the data collection time. The Roland-Morris Scale is a simple yes/no questionnaire that addresses the effect of back pain on ADLs, but it does not allow for graded responses nor does it address the extent of pain or its effect on a patient's mood. 14 The 36-Item Short Form Health Survey is a general health questionnaire that addresses health status in patients of all ages and does not focus on back pain. 17 The ODI questionnaire is a frequently used instrument, but it is limited to measuring 10 dimensions of low-back pain and functional disability and does not capture the extent of pain.
patients undergoing percutaneous PMMA-augmented vertebroplasty and reported on pain reduction and improvement in functional mobility among 245 patients with VCFs who underwent vertebroplasty. 4 Since this initial effort, we have revised the instrument and now report on its psychometric properties obtained in 72 more recently treated patients.
Clinical Material and Methods

Instrument Development
In late 1998 and early 1999, through reviewing the literature and meetings with vertebroplasty surgeons and data management specialists at the Jaeb Center for Health Research in Tampa, Florida, we developed a pilot instrument with which to collect information from patients with vertebral fractures undergoing percutaneous PMMA-augmented vertebroplasty. In addition to acquiring demographic and medical history information, the pilot instrument included 12 questions on the date and cause of the fracture(s) as well as assessments of pain (score range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] , ambulation (score range 1 [normal/no pain]-5 [bedridden]), ability to perform ADLs (score range 1 [able to do without pain]-5 [cannot do because of pain]), and level of medication usage. In accordance with an institutional review board-approved protocol, 245 vertebroplastytreated patients at seven university-based and private hospitals (Tampa, FL, Ft. Myers, FL, Little Rock, AK, Indianapolis, IN, Atlanta, GA, Charlottesville, VA, and Madisonville, KY) were interviewed by telephone. Patients were asked to retrospectively recall their level of pain and functional status before and immediately after undergoing percutaneous PMMA-augmented vertebroplasty. The time from the procedure to the telephone interview varied, with a median interval of 7.2 months (25th percentile, 3.1 months; 75th percentile, 13.6 months). Results from this data collection effort have been published. 4 From a research perspective, three of the most salient lessons learned from the initial pilot study were as follows: 1) the need to minimize the length of time for patient recall and data collection related to the vertebroplasty procedure; 2) the need for an expanded and comprehensive list of ADLs pertinent to this patient subgroup; and 3) the need to collect pain and functional status information simultaneously using a separate previously developed instrument for validation purposes. Therefore, the initial pilot instrument has been revised to include an expanded list of ADLs, and has been appended with the ODI. The ODI is a frequently used reliable and valid instrument that measures 10 dimensions of low-back pain and functional disability on a six-point scale (range 0 [least affected]-5 [most affected]). In addition, separate versions of the revised instrument have been developed to allow prospective collection of data immediately prior to the surgery (baseline questionnaire) and at desired followup intervals (follow-up questionnaire).
Questionnaire Content and Scoring
The first section of the baseline questionnaire contains a total of 11 items that address the patient's prior and current magnitude of back pain and distress, overall general health, use of prescription medications for conditions unrelated to the fracture, and expected treatment-related relief of back pain. Three pain-related items are measured using a VAS with scores ranging from 0 (no pain) to 10 (pain as bad as it could be), representing pain status at three periods: "right now," "maximum in the last 24 hours," and "minimum in the last 24 hours." Two additional pain items are measured using an adjectival scale on which the scores range from 0 (none) to 8 (very intense), representing two periods: "within the last 24 hours" and "before this back fracture." Two distress-related items within the last 24 hours (due to the patient's back condition) are measured using either a VAS, with scores ranging from 0 (not at all distressing) to 10 (very intolerable), or an adjectival scale with scores ranging from 0 (not at all distressing) to 8 (unbearable). The remaining four items are measured using either a five-point Likert Scale or dichotomous yes/no responses. The 11 items in this section are designed for independent scoring and interpretation.
The second section of the baseline questionnaire lists 24 ADLs. The ability to perform each activity is assessed at two intervals: before the patient's recent onset of back pain and at the time of responding to the questionnaire. Thus, assessment of the prior ability to perform ADLs requires retrospective recall by the patient. The current ability to perform each activity is measured on a four-point scale in which the scores range from 1 (absolutely unable to do because of pain) to 4 (able to do without pain). In addition, there is a response box to identify if the patient does not perform a particular daily activity. The prior ability to perform each activity is measured on a four-point scale, with scores ranging from 1 (absolutely unable to do) to 4 (able to do without difficulty).
The follow-up questionnaire parallels the baseline questionnaire with the identical seven pain-and distress-related items in the first section, and the same 24 ADLs related to current level of back pain in the second section. Thus, scores on these items are directly comparable between baseline and follow-up assessments, and difference scores can be calculated. In addition, for the 24 ADLs listed in both questionnaires, an average ADL ability score can be obtained by summing responses from all ADLs performed and dividing by the number of ADLs performed.
Because measures of pain and distress with VAS and adjectival scales are well described and accepted, the present study focuses on the psychometric properties of the 24 ADLs listed in the second section of the baseline and follow-up questionnaires.
Study Population and Questionnaire Administration
Following an institutional review board-approved protocol, patients undergoing percutaneous PMMA-augmented vertebroplasty were invited to complete the baseline questionnaire. After informed consent was obtained, each participant was given the baseline questionnaire to fill out the day of the procedure. Postprocedure questionnaires were mailed to the participant at 1 and 6 weeks, along with a self-addressed stamped return envelope. Instructions were printed at the top of each questionnaire that stated each would take approximately 30 minutes to complete and to answer all questions as they appeared on the form.
Of the 72 patients who provided consent and baseline information on ADLs performed prior to surgery, 71 (98.6%) returned the follow-up questionnaire at a median time of 20 days (25th percentile, 10 days; 75th percentile, 26 days) postoperatively. In addition, 68 (94.4%) of these 72 patients returned the second follow-up questionnaire at a median of 49 days (25th percentile, 40 days; 75th percentile, 64 days) after completing the first follow-up questionnaire. Of these 72 patients, the mean age was 74 Ϯ 10 years, 80% were female, and 100% were Caucasian. Prior to surgery, 13% of all patients reported complete inability to ambulate, and 46% reported being able to walk less than one block. In addition, 7% of all patients were bedridden and 15% required use of a wheelchair.
Statistical Analysis
The internal consistency reliability of the 24 ADL items was estimated using the coefficient alpha. This included assessment at the baseline and both follow-up administrations of the questionnaires. Since ADLs may be expected to change after vertebroplasty, the reliability estimates do not represent test-retest reliability but rather the internal consistency (reliability) of the instrument assessed at three different time points. Because most respondents did not report performing all 24 ADLs, separate coefficient alpha estimates were calculated among the subsets of ADL items performed by more than 80% or more than 90% of all respondents. In addition, Spearman rank correlation coefficients were calculated between scores on each ADL and the average ADL score among all ADLs performed.
To assess concurrent validity of the questionnaire in relation to multiple measures (that is, does the questionnaire measure what it is intended to measure), Spearman correlation coefficients were calculated between individual ADL scores from the questionnaire and pain and distress items from the first section of the questionnaire (internal source), as well as with scores on the 10 dimensions of the ODI (external source). In addition, average scores among all ADLs were correlated with average scores among all 10 dimensions of the ODI questionnaire. Thus, this approach aims to evaluate the relationship between ADL scores from the questionnaire and other measures of pain, distress, and functional ability. Because ability to perform ADLs is not related to a single patient factor or condition (for example, pain or distress), we do not expect validity coefficients to be near perfect (that is, an r value of 1.0). The correlations between the questionnaire ADLs and the ODI dimensions are reported for the baseline and first follow-up data collection. Results from the second follow-up data collection were essentially identical to those from the first follow-up data collection.
We did not attempt to validate the questionnaire in a control group of individuals without VCFs. Our aim instead was to assess the extent to which the instrument reliably measures components of functional ability in patients with compression fractures before and after treatment, rather than being able to discriminate performance in conducting ADLs among individuals with and without VCFs.
Results
Internal Consistency Reliability
At the baseline administration, the internal consistency reliability estimates for the ADL items were very high, ranging from 0.89 to 0.94, depending on whether the assessment was among respondents who performed all 24 ADLs or the subsets of ADL items performed by either more than 80% or 90% of respondents (Table 1) . Similar very high reliability estimates were obtained at the first and second follow-up administrations. Thus, the questionnaire's measurement of ADLs appears to be repeatable. Rank correlations between individual ADL scores and the average score among all ADLs performed were similar among the baseline and two follow-up administrations and were generally high, ranging from 0.55 to 0.97. Thus, each individual ADL appears to measure an aspect of one's general ability to perform ADLs. Although the incidence of respondents who performed each ADL was modestly higher at the baseline administration than at either follow-up administration, the mean score of ability to perform ADLs was higher in the first and second postoperative visits than at baseline (3.7, 3.8, and 2.7, respectively). The ADLs least often performed included lifting heavy objects, using public transportation, gardening, and doing heavy housework.
Correlations of ADLs With Internal Measures of Pain and Distress
At the baseline administration, rank correlations between the average score of all ADLs performed and concurrent questionnaire measures of pain and distress ranged from 0.29 to 0.51 (Table 2) . When substituting the "maximum" and "minimum" VAS pain measures at baseline (for the pain "right now" measure), correlations with the average score of all ADLs performed were 0.22 and 0.23, respectively. Relatively higher correlations were observed at the first follow-up administration, ranging from 0.51 to 0.72 (Table 2) . At both administrations, scores from the 24 ADLs generally correlated least with the VAS score of current pain (pain "right now") and most with the adjectival measure of distress ("within the last 24 hours"). With the exception of the null correlation between the ADL "pursuing an interest or hobby" and the VAS pain score at the baseline administration (r = 0.00), all other correlation pairs were positive in direction, albeit varying widely in magnitude from nominal to strong.
Correlations of ADLs With the ODI
Correlations between the average score of all ADLs performed at the baseline administration and the 10 dimensions of the ODI questionnaire were modest to high, ranging from 0.37 to 0.63 (Table 3 ). The corresponding correlation between the average scores of all ADLs performed and all ODI dimensions was 0.65. Unlike results using the VAS pain score, correlations between the 24 ADLs and the ODI "pain intensity" dimension were not appreciably lower than those with the nine other ODI dimensions.
At the first follow-up administration, correlations between the average score of all ADLs performed and the 10 dimensions of the ODI questionnaire were modest to high, ranging from 0.35 to 0.59 (Table 4 ). The corresponding correlation between the average scores of all ADLs performed and all ODI dimensions was 0.32. Thus, generally similar validation results were observed among the baseline and follow-up administrations.
Discussion
In our aging population, the incidence of osteoporotic fractures will increase fourfold worldwide during the next 50 years and the attendant cost will threaten the viability of healthcare systems of many countries. 13 This epidemiological imperative, as well as the advent of minimally invasive techniques (such as percutaneous PMMA-based vertebroplasty) to treat VCFs, has created a need for research to evaluate the efficacy of these new therapies to ensure that rational choices may be made concerning the allocation of healthcare resources to the most effective means of therapy.
Vertebral compression fractures are the most common osteoporotic fracture, yet until now there has been no single specifically designed, validated instrument to measure the pain and functional disability associated with these fractures in elderly patients. For instance, the Investigational Vertebroplasty Efficacy and Safety Trial 10 sponsored by the National Institutes of Health depends upon 10 different questionnaires to capture a sufficient quantity of relevant data related to back pain and its effects in elderly patients. The time involved in completing this collection of questionnaires and the redundancy of much of the information make it less than ideal. The aim of the present study was to develop a single questionnaire that can be completed in a reasonable period of time in routine clinical practice and that can be used to assess multiple aspects of back pain relevant to elderly patients with VCFs.
The Vertebral Compression Fracture Pain and Functional Disability Questionnaire was developed in a busy clinical practice to address the need for rapid data collection from elderly patients. It can be rapidly completed (typically in Ͻ 30 minutes) and can be self-administered or read to the patient. It contains multiple elements of other validated questionnaires that were specifically chosen because of their relevance to this age population. Not all of the ADLs are performed by every patient, but the fact that most patients perform the majority of these activities supports the relevance of this instrument. Moreover, for ADLs not performed, the response option "do not perform" aids in consistent data collection for each patient.
Psychometric Properties
The internal consistency reliability of the 24 ADL items was very high (range 0.87-0.98) at measurement intervals before and after vertebroplasty, indicating that measurements of functional ability can be reliably ascertained over time. This is a necessary condition for accurately evaluat- * Avg = average; Corr = correlation; FU = follow up; SD = standard deviation. † Between one to four patients were excluded from the total number of 72 patients because they reported not performing any of the 24 ADLs.
ing change in functional ability; however, an explanation for the paradoxical finding that after vertebroplasty fewer patients appeared to perform some ADLs, despite having less difficulty overall in performing ADLs, is not intuitively obvious. Most patients were counseled that they should avoid bending and heavy lifting now that they have had a VCF and a diagnosis of osteoporosis. Thus, the fact that fewer patients performed such activities as heavy lifting and heavy housework most likely reflects adherence to a doctor's orders, rather than any change for the worse in the patients' condition, especially because, overall, most patients experienced an improvement in functional ability.
In terms of concurrent validity, we observed modest to strong correlations between the 24 ADLs and internal measures of pain and distress measured on both VAS and adjectival scales. Similar evidence of concurrent validity was observed between the questionnaire and the 10 dimensions of the ODI. Moreover, as with estimates of internal consistency reliability, the evidence in support of validity of the questionnaire was stable over time (before and after vertebroplasty treatment). Although some of the correlation coefficients (validity estimates) were modest (for example, r = 0.29 for the VAS measure of current pain), the ADLs were positively associated with all measures of pain and distress and all dimensions of the ODI questionnaire, both before and after treatment. Thus, in aggregate, our data indicate that the Vertebral Compression Fracture Pain and Functional Disability Questionnaire appears to be a reliable and valid instrument for measuring functional ability in elderly patients before and after treatment for VCFs.
Limitations of the Questionnaire
The Vertebral Compression Fracture Pain and Functional Disability Questionnaire does have limitations. It does not address in detail general health concerns, perception of treatment, or use of medications. Other instruments are readily available to address these concerns. In addition, our study population was entirely Caucasian. During the study period, not a single African-American patient presented for treatment. As is well known, VCFs are very uncommon in the African-American population. We would not claim that the instrument is necessarily valid for
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A new pain and functional disability questionnaire 221 * The ADLs were reverse scored so that higher scores correspond to greater disability. † The effective number of patients ranges from 41 to 72 depending on missing data and if the ADL was performed by the respondent at baseline. ‡ The effective number of patients ranges from 11 to 69 depending on missing data and if the ADL was performed by the respondent at first follow up.
§ The scores range from 0 (no pain) to 10 (pain as bad as it could be). || The scores range from 0 (none) to 8 (very intense). ** The scores range from 0 (not at all distressing) to 10 (very intolerable). † † The scores range from 0 (not at all distressing) to 8 (unbearable). other races, although future assessment across other races and ethnicities could be undertaken. Similarly, most patients in our population were female, and despite similar results observed by sex (data not shown), the questionnaire could be applied in a larger cohort of male patients, although this would be difficult in that VCFs are significantly less common in men. In short, the validation was performed primarily in the patient population that is most likely to suffer from VCFs.
Additionally, it would be instructive to conduct a factor analysis to explore underlying ADL dimensions among the set of 24 ADLs. However, the relatively small sample of 72 patients in this study and the fact that not all ADLs were performed by all patients precluded the feasibility of this type of analysis. We hope to address this issue with further investigation.
Use in Clinical Practice
The ODI was appended to this questionnaire to provide a means to gauge the effectiveness of the questionnaire. The ODI need not be included with the questionnaire when it is being administered.
The Vertebral Compression Fracture Pain and Functional Disability Questionnaire is specifically designed so that difference scores can be created between baseline and follow-up measures to measure change in functional status over time after interventions or to evaluate the natural history of the disease in untreated or control individuals. Psychometric properties of these change scores were not addressed in this report but are the subject of a second paper more focused on patient outcome following percutaneous PMMA-augmented vertebroplasty.
Conclusions
The Vertebral Compression Fracture Pain and Functional Disability Questionnaire appears to be a reliable and valid instrument for assessing back pain and functional ability in patients before and after treatment for VCFs.
